Last update :
28/01/2023
Anticancer drug   Hydroxyurea  
Oral solution
Stability of pharmaceutical preparations Stability of mixtures Factors which affect stability Compatibility References Pdf
   Chemical structure  

Oral solution
Stability of pharmaceutical preparations   Oral solution   Stability of pharmaceutical preparations : Hydroxyurea     
Container Origine Excipient Temperature Storage Duration of stability References
Glass Powder 6000 mg
® = Inresa
OraPlus® / OraSweet® (1:1) >> 60 mL
22-25°C Protect from light
120 Day
3963

Glass Powder 6000 mg
® = Inresa
OraPlus® / OraSweet SF® (1:1) >> 60 mL
22-25°C Protect from light
120 Day
3963

Glass Powder 6000 mg
® = Inresa
Orablend® >> 60 mL
22-25°C Protect from light
120 Day
3963

Glass Powder 6000 mg
® = Inresa
Orablend SF® >> 60 mL
22-25°C Protect from light
120 Day
3963

Glass Powder 6000 mg
® = Inresa
OraPlus® / OraSweet® (1:1) >> 60 mL
4-8°C Protect from light
120 Day
3963

Glass Powder 6000 mg
® = Inresa
OraPlus® / OraSweet SF® (1:1) >> 60 mL
4-8°C Protect from light
120 Day
3963

Glass Powder 6000 mg
® = Inresa
Orablend® >> 60 mL
4-8°C Protect from light
120 Day
3963

Glass Powder 6000 mg
® = Inresa
Orablend SF® >> 60 mL
4-8°C Protect from light
120 Day
3963

Plastic bottle Tablets 5000 mg
® = Mylan
Orablend® >> 50 mL
23-27°C Protect from light
90 Day
4694
Plastic bottle Tablets 5000 mg
® = Bristol Myers Squibb
Orablend® >> 50 mL
23-27°C Protect from light
90 Day
4694
Plastic bottle Powder 5000 mg
® = ?
Orablend® >> 50 mL
23-27°C Protect from light
90 Day
4694
Plastic bottle Kapseln 10 g
Hydrea®
Water for injection 50 ml
Syrpalta® >> 100 ml
25°C Protect from light
90 Day
2723

Syringe Tablets 300 mg
® = Mylan
Orablend® >> 3 mL
23-27°C Protect from light
14 Day
4694
Syringe Powder 300 mg
® = ?
Orablend® >> 3 mL
23-27°C Protect from light
14 Day
4694
Syringe Tablets 300 mg
® = Bristol Myers Squibb
Orablend® >> 3 mL
23-27°C Protect from light
14 Day
4694

  Mentions Légales